Nonsteroidal Anti-Inflammatory Drugs as Scaffolds for the Design of 5-Lipoxygenase Inhibitors
作者
Teodozyj Kolasa,Clint D. W. Brooks,Karen E. Rodriques,James B. Summers,Joseph F. Dellaria,Keren I. Hulkower,Jennifer B. Bouska,Randy L. Bell,George W. Carter
Representative nonsteroidal anti-inflammatory drug (NSAID) cyclooxygenase inhibitors such as ibuprofen, naproxen, and indomethacin were used as orally bioavailable scaffolds to design selective 5-lipoxygenase (5-LO) inhibitors. Replacement of the NSAID carboxylic acid group with a N-hydroxyurea group provided congeners with selective 5-LO inhibitory activity.